External

Main navigation

MEG@51吃瓜网Comprehensive Training (Second Edition)

Monday, November 16, 2015toFriday, November 20, 2015

It is with great pleasure that we are announcing the 2nd edition of the MEG@51吃瓜网Comprehensive Training Program in 2015.3801 rue University, Montreal, QC, H3A 2B4, CA/bicCategory:聽MNI

Read more about MEG@51吃瓜网Comprehensive Training (Second Edition)

2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

Thursday, November 13, 2025 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro鈥檚 premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

Read more about 2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

8th National Neuromuscular Review Course

Friday, October 24, 2025 09:00toSaturday, October 25, 2025 17:00

Dr. Nicolas Dupr茅 of Laval University, Dr. Karine Garneau of Universit茅 de Montr茅al, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course...

Read more about 8th National Neuromuscular Review Course

6th National Course on Sleep Medicine

Friday, November 28, 2025 09:00toSaturday, November 29, 2025 16:00

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.3801 rue University, Montreal, QC, H3A 2B4, CA/neuroCategory:聽Medicine Research...

Read more about 6th National Course on Sleep Medicine

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Read more about Genetic sequencing project receives more than $8 million in funding

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson鈥檚, glioblastoma and dementia 聽

Read more about Six principal investigators from The Neuro receive CIHR grants

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...